Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > MMED - no Phase I = $300M valuation; TLT = peanuts

<< Previous

Bullboard Posts

Next >>

Post by RichieRich123on Oct 22, 2020 8:25pm

137 Views

Post# 31769320

MMED - no Phase I = $300M valuation; TLT = peanuts

I own a lot of shares of MMED that are 35% in the money which I love, but they don't even have a Phase I yet.

TLT is in Phase IIb with a lot of indications/irons in the fire...and valuation is a tiny fraction of MMED.

What gives???? Seriously. What is really going on here?????

What is wrong with TLT??????????

All in my opinion

<< Previous

Bullboard Posts

Next >>

Pinnacle Silver & Gold: A promising precious metals investment